Gamma Medica, Inc. is focused on overcoming the critical shortcomings of mammography and other screening modalities in the early detection of breast cancer. The LumaGEM® MBI system is the first commercially available, FDA-cleared, fully solid-state digital imaging system. With over 90% sensitivity and specificity, LumaGEM MBI has been shown to significantly improve cancer detection in women with dense breast tissue with fewer false positives.